Cornelia Reininger
- Psychiatry and Mental health top 1%
- Dementia and Cognitive Impairment Research 18
- Physiology top 2%
- Alzheimer's disease research and treatments 19
- Neurology top 5%
-
- Medical Imaging Techniques and Applications 20
- Radiomics and Machine Learning in Medical Imaging 5
- Radiopharmaceutical Chemistry and Applications 5
- Neurology top 5%
-
- Venous Thromboembolism Diagnosis and Management 8
-
- Antiplatelet Therapy and Cardiovascular Diseases 6
-
- Platelet Disorders and Treatments 5
Cornelia Reininger
56 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Psychiatry and Mental health 1.0k
- Physiology 1.0k
- Neurology 413
- Radiology, Nuclear Medicine and Imaging 577
- Neurology 200
Countries citing papers authored by Cornelia Reininger
This map shows the geographic impact of Cornelia Reininger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Reininger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Reininger more than expected).
Fields of papers citing papers by Cornelia Reininger
This network shows the impact of papers produced by Cornelia Reininger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Reininger. The network helps show where Cornelia Reininger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cornelia Reininger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 54 | |
| 2 | 2012 | 28 | |
| 3 | Multicentre phase 3 trial on florbetaben for β-amyloid brain PET in Alzheimer disease | 2012 | 2 |
| 4 | Global phase 2b efficacy and safety trial of florbetaben for beta-amyloid brain positron emission tomography in Alzheimer's disease | 2011 | 1 |
| 5 | 2011 | 84 | |
| 6 | Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic studybreakdown → | 2011 | 434 |
| 7 | 2011 | 266 | |
| 8 | 2010 | 1 | |
| 9 | 2008 | 96 | |
| 10 | 2007 | 419 | |
| 11 | 2006 | 74 | |
| 12 | 2004 | 18 | |
| 13 | 2001 | 32 | |
| 14 | 1999 | 5 | |
| 15 | 1997 | 1 | |
| 16 | 1996 | 35 | |
| 17 | 1996 | 25 | |
| 18 | 1994 | 28 | |
| 19 | 1993 | 10 | |
| 20 | 1992 | 12 |
About Cornelia Reininger
Cornelia Reininger is a scholar working on Internal Medicine, Psychiatry and Mental health, Radiology, Nuclear Medicine and Imaging, Physiology and Hematology, having authored 61 papers that have together received 2.1k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (20 papers), Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (18 papers), Venous Thromboembolism Diagnosis and Management (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Platelet Disorders and Treatments (5 papers). The work is most often cited by research in Psychiatry and Mental health (1.0k citations), Physiology (1.0k citations), Neurology (413 citations), Radiology, Nuclear Medicine and Imaging (577 citations) and Neurology (200 citations). Cornelia Reininger has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Osama Sabri, Henryk Barthel, Hermann‐Josef Gertz, John Seibyl, Oliver Peters, Peter Bartenstein, Beate Rohde, S. Dresel, Florian Hiemeyer and Klaus Tatsch. Their work appears in journals such as Alzheimer s & Dementia, Thrombosis Research, Thrombosis and Haemostasis, Journal of Nuclear Medicine and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.